These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15970675)
1. VAV1: a new target in pancreatic cancer? Denicola G; Tuveson DA Cancer Biol Ther; 2005 May; 4(5):509-11. PubMed ID: 15970675 [TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748 [TBL] [Abstract][Full Text] [Related]
3. Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1. Razidlo GL; Wang Y; Chen J; Krueger EW; Billadeau DD; McNiven MA Dev Cell; 2013 Mar; 24(6):573-85. PubMed ID: 23537630 [TBL] [Abstract][Full Text] [Related]
4. Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice. Salaymeh Y; Farago M; Sebban S; Shalom B; Pikarsky E; Katzav S Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32277014 [TBL] [Abstract][Full Text] [Related]
5. Human Vav1 expression in hematopoietic and cancer cell lines is regulated by c-Myb and by CpG methylation. Ilan L; Katzav S PLoS One; 2012; 7(1):e29939. PubMed ID: 22253833 [TBL] [Abstract][Full Text] [Related]
6. TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1. Huang PH; Lu PJ; Ding LY; Chu PC; Hsu WY; Chen CS; Tsao CC; Chen BH; Lee CT; Shan YS; Chen CS Oncogene; 2017 Apr; 36(16):2202-2214. PubMed ID: 27893715 [TBL] [Abstract][Full Text] [Related]
7. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis. Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802 [TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features. Zhao L; Cui Q; Lu Z; Chen J Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082 [TBL] [Abstract][Full Text] [Related]
9. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4. Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282 [TBL] [Abstract][Full Text] [Related]
10. Early requirement of Rac1 in a mouse model of pancreatic cancer. Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285 [TBL] [Abstract][Full Text] [Related]
12. Mutation of Vav1 adaptor region reveals a new oncogenic activation. Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554 [TBL] [Abstract][Full Text] [Related]
13. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression. Wan C; Gong C; Zhang H; Hua L; Li X; Chen X; Chen Y; Ding X; He S; Cao W; Wang Y; Fan S; Xiao Y; Zhou G; Shen A Cancer Lett; 2016 Apr; 373(1):67-76. PubMed ID: 26803058 [TBL] [Abstract][Full Text] [Related]
14. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion. Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335 [TBL] [Abstract][Full Text] [Related]
15. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is associated with the inhibition of Akt/NF-кB/mTOR prosurvival signaling. Deeb D; Gao X; Liu Y; Zhang Y; Shaw J; Valeriote FA; Gautam SC Int J Oncol; 2016 Sep; 49(3):1139-47. PubMed ID: 27573873 [TBL] [Abstract][Full Text] [Related]
16. ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer. Somerville TDD; Xu Y; Wu XS; Maia-Silva D; Hur SK; de Almeida LMN; Preall JB; Koo PK; Vakoc CR Proc Natl Acad Sci U S A; 2020 May; 117(21):11471-11482. PubMed ID: 32385160 [TBL] [Abstract][Full Text] [Related]
17. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332 [TBL] [Abstract][Full Text] [Related]
18. Vav1 as a central regulator of invadopodia assembly. Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539 [TBL] [Abstract][Full Text] [Related]
19. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962 [TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma. Sullivan J; Blair L; Alnajar A; Aziz T; Chipitsyna G; Gong Q; Yeo CJ; Arafat HA Histol Histopathol; 2011 Jul; 26(7):893-904. PubMed ID: 21630219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]